Codi QR

Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study

Not available.

Guardat en:
Autors principals: Thomas Chalopin, Cyrille Hulin, Bruno Royer, Jean-Noel Bastie, Arthur Bobin, Karim Belhadj Merzoug, Margaret Macro, Lionel Karlin, Caroline Jacquet, Mohamad Mohty, Laurent Frenzel, Cécile Sonntag, Jean Fontan, Sophie Rigaudeau, Murielle Roussel, Laurence Sanhes, Driss Chaoui, Laure Vincent, Hubert Orfeuvre, Malek Bouketouche, Ronan Garlantezec, Olivier Decaux, Aurore Perrot
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2025-08-01
Col·lecció:Haematologica
Accés en línia:https://haematologica.org/article/view/12238
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars